- call +1-201-465-4211
- email sales@mrinsights.biz
Visceral pain is pain that results from the activation of nociceptors of the thoracic, pelvic, or abdominal viscera (organs). Visceral structures are highly sensitive to distension (stretch), ischemia and inflammation, but relatively insensitive to other stimuli that normally evoke pain such as cutting or burning. Visceral pain is diffuse, difficult to localize and often referred to a distant, usually superficial, structure. It may be accompanied by symptoms such as nausea, vomiting, changes in vital signs as well as emotional manifestations. The pain may be described as sickening, deep, squeezing, and dull. Distinct structural lesions or biochemical abnormalities explain this type of pain in only a proportion of patients. These diseases are grouped under gastrointestinal neuromuscular diseases (GINMD). Others can experience visceral pains, often very intense in nature, without any evidence of structural, biochemical or histolopathologic reason for such symptoms. These diseases are grouped under functional gastrointestinal disorders (FGID) and the pathophysiology and treatment can vary greatly from GINMD. The two major single entities among functional disorders of the gut are functional dyspepsia and irritable bowel syndrome.
Scope of the Report:
This report focuses on the Visceral Pain in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Growing focus on research and development by pharmaceutical companies and government initiatives are expected to boost the visceral pain industry over the forecast period. The market is projected to witness significant gain during the forecast period owing to increasing collaboration within pharmaceutical companies. Moreover, growth in the interest of scientists and researchers in studying the pain originating from internal organs has mirrored in the consciousness of the importance of visceral pain in patients. Asia Pacific is expected to grow at the highest CAGR of 6.2% from 2017 to 2024. North America has been leading the market for visceral pain, it is expected that African countries will witness exponential growth during the forecast period.
The worldwide market for Visceral Pain is expected to grow at a CAGR of roughly 3.6% over the next five years, will reach 1260 million US$ in 2023, from 1020 million US$ in 2017, according to a new study.
Market Segment by Manufacturers, this report covers
Pfizer
Johnson & Johnson
Abbvie
Takeda
Allergan
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Analgesics
Pain Modifiers
Market Segment by Applications, can be divided into
Interstitial Cystitis
Crohn’s
Irritable Bowel
Chronic Prostatitis
There are 15 Chapters to deeply display the global Visceral Pain market.
Chapter 1, to describe Visceral Pain Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Visceral Pain, with sales, revenue, and price of Visceral Pain, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Visceral Pain, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Visceral Pain market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Visceral Pain sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Visceral Pain Introduction
1.2 Market Analysis by Type
1.2.1 Analgesics
1.2.2 Pain Modifiers
1.3 Market Analysis by Applications
1.3.1 Interstitial Cystitis
1.3.2 Crohn’s
1.3.3 Irritable Bowel
1.3.4 Chronic Prostatitis
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.1.1 Pfizer Description
2.1.1.2 Pfizer Headquarter, Main Business and Finance Overview
2.1.2 Pfizer Visceral Pain Product Introduction
2.1.2.1 Visceral Pain Production Bases, Sales Regions and Major Competitors
2.1.2.2 Visceral Pain Product Information
2.1.3 Pfizer Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.1 Pfizer Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.3.2 Global Pfizer Visceral Pain Market Share in 2017
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.1.1 Johnson & Johnson Description
2.2.1.2 Johnson & Johnson Headquarter, Main Business and Finance Overview
2.2.2 Johnson & Johnson Visceral Pain Product Introduction
2.2.2.1 Visceral Pain Production Bases, Sales Regions and Major Competitors
2.2.2.2 Visceral Pain Product Information
2.2.3 Johnson & Johnson Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.1 Johnson & Johnson Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.3.2 Global Johnson & Johnson Visceral Pain Market Share in 2017
2.3 Abbvie
2.3.1 Business Overview
2.3.1.1 Abbvie Description
2.3.1.2 Abbvie Headquarter, Main Business and Finance Overview
2.3.2 Abbvie Visceral Pain Product Introduction
2.3.2.1 Visceral Pain Production Bases, Sales Regions and Major Competitors
2.3.2.2 Visceral Pain Product Information
2.3.3 Abbvie Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.1 Abbvie Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.3.2 Global Abbvie Visceral Pain Market Share in 2017
2.4 Takeda
2.4.1 Business Overview
2.4.1.1 Takeda Description
2.4.1.2 Takeda Headquarter, Main Business and Finance Overview
2.4.2 Takeda Visceral Pain Product Introduction
2.4.2.1 Visceral Pain Production Bases, Sales Regions and Major Competitors
2.4.2.2 Visceral Pain Product Information
2.4.3 Takeda Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.1 Takeda Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.3.2 Global Takeda Visceral Pain Market Share in 2017
2.5 Allergan
2.5.1 Business Overview
2.5.1.1 Allergan Description
2.5.1.2 Allergan Headquarter, Main Business and Finance Overview
2.5.2 Allergan Visceral Pain Product Introduction
2.5.2.1 Visceral Pain Production Bases, Sales Regions and Major Competitors
2.5.2.2 Visceral Pain Product Information
2.5.3 Allergan Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.1 Allergan Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.3.2 Global Allergan Visceral Pain Market Share in 2017
2.6 AstraZeneca
2.6.1 Business Overview
2.6.1.1 AstraZeneca Description
2.6.1.2 AstraZeneca Headquarter, Main Business and Finance Overview
2.6.2 AstraZeneca Visceral Pain Product Introduction
2.6.2.1 Visceral Pain Production Bases, Sales Regions and Major Competitors
2.6.2.2 Visceral Pain Product Information
2.6.3 AstraZeneca Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.1 AstraZeneca Visceral Pain Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.3.2 Global AstraZeneca Visceral Pain Market Share in 2017
3 Global Visceral Pain Market Competition, by Manufacturer
3.1 Global Visceral Pain Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Visceral Pain Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Visceral Pain Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Visceral Pain Manufacturer Market Share in 2017
3.4.2 Top 5 Visceral Pain Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global Visceral Pain Market Analysis by Regions
4.1 Global Visceral Pain Sales, Revenue and Market Share by Regions
4.1.1 Global Visceral Pain Sales by Regions (2013-2018)
4.1.2 Global Visceral Pain Revenue by Regions (2013-2018)
4.2 North America Visceral Pain Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Visceral Pain Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Visceral Pain Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Visceral Pain Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Visceral Pain Sales, Revenue and Growth Rate (2013-2018)
5 North America Visceral Pain by Countries, Type, Application and Manufacturers
5.1 North America Visceral Pain Sales, Revenue and Market Share by Countries
5.1.1 North America Visceral Pain Sales by Countries (2013-2018)
5.1.2 North America Visceral Pain Revenue by Countries (2013-2018)
5.1.3 United States Visceral Pain Sales and Growth Rate (2013-2018)
5.1.4 Canada Visceral Pain Sales and Growth Rate (2013-2018)
5.1.5 Mexico Visceral Pain Sales and Growth Rate (2013-2018)
5.2 North America Visceral Pain Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America Visceral Pain Sales by Manufacturers (2016-2017)
5.2.2 North America Visceral Pain Revenue by Manufacturers (2016-2017)
5.3 North America Visceral Pain Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America Visceral Pain Sales and Sales Share by Type (2013-2018)
5.3.2 North America Visceral Pain Revenue and Revenue Share by Type (2013-2018)
5.4 North America Visceral Pain Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America Visceral Pain Sales and Sales Share by Application (2013-2018)
5.4.2 North America Visceral Pain Revenue and Revenue Share by Application (2013-2018)
6 Europe Visceral Pain by Countries, Type, Application and Manufacturers
6.1 Europe Visceral Pain Sales, Revenue and Market Share by Countries
6.1.1 Europe Visceral Pain Sales by Countries (2013-2018)
6.1.2 Europe Visceral Pain Revenue by Countries (2013-2018)
6.1.3 Germany Visceral Pain Sales and Growth Rate (2013-2018)
6.1.4 UK Visceral Pain Sales and Growth Rate (2013-2018)
6.1.5 France Visceral Pain Sales and Growth Rate (2013-2018)
6.1.6 Russia Visceral Pain Sales and Growth Rate (2013-2018)
6.1.7 Italy Visceral Pain Sales and Growth Rate (2013-2018)
6.2 Europe Visceral Pain Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe Visceral Pain Sales by Manufacturers (2016-2017)
6.2.2 Europe Visceral Pain Revenue by Manufacturers (2016-2017)
6.3 Europe Visceral Pain Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe Visceral Pain Sales and Sales Share by Type (2013-2018)
6.3.2 Europe Visceral Pain Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Visceral Pain Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe Visceral Pain Sales and Sales Share by Application (2013-2018)
6.4.2 Europe Visceral Pain Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific Visceral Pain by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific Visceral Pain Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Visceral Pain Sales by Countries (2013-2018)
7.1.2 Asia-Pacific Visceral Pain Revenue by Countries (2013-2018)
7.1.3 China Visceral Pain Sales and Growth Rate (2013-2018)
7.1.4 Japan Visceral Pain Sales and Growth Rate (2013-2018)
7.1.5 Korea Visceral Pain Sales and Growth Rate (2013-2018)
7.1.6 India Visceral Pain Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia Visceral Pain Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Visceral Pain Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific Visceral Pain Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific Visceral Pain Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Visceral Pain Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific Visceral Pain Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific Visceral Pain Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Visceral Pain Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific Visceral Pain Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific Visceral Pain Revenue and Revenue Share by Application (2013-2018)
8 South America Visceral Pain by Countries, Type, Application and Manufacturers
8.1 South America Visceral Pain Sales, Revenue and Market Share by Countries
8.1.1 South America Visceral Pain Sales by Countries (2013-2018)
8.1.2 South America Visceral Pain Revenue by Countries (2013-2018)
8.1.3 Brazil Visceral Pain Sales and Growth Rate (2013-2018)
8.1.4 Argentina Visceral Pain Sales and Growth Rate (2013-2018)
8.1.5 Colombia Visceral Pain Sales and Growth Rate (2013-2018)
8.2 South America Visceral Pain Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America Visceral Pain Sales by Manufacturers (2016-2017)
8.2.2 South America Visceral Pain Revenue by Manufacturers (2016-2017)
8.3 South America Visceral Pain Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America Visceral Pain Sales and Sales Share by Type (2013-2018)
8.3.2 South America Visceral Pain Revenue and Revenue Share by Type (2013-2018)
8.4 South America Visceral Pain Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America Visceral Pain Sales and Sales Share by Application (2013-2018)
8.4.2 South America Visceral Pain Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa Visceral Pain by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa Visceral Pain Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Visceral Pain Sales by Countries (2013-2018)
9.1.2 Middle East and Africa Visceral Pain Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia Visceral Pain Sales and Growth Rate (2013-2018)
9.1.4 UAE Visceral Pain Sales and Growth Rate (2013-2018)
9.1.5 Egypt Visceral Pain Sales and Growth Rate (2013-2018)
9.1.6 Nigeria Visceral Pain Sales and Growth Rate (2013-2018)
9.1.7 South Africa Visceral Pain Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Visceral Pain Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa Visceral Pain Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa Visceral Pain Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Visceral Pain Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa Visceral Pain Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa Visceral Pain Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Visceral Pain Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa Visceral Pain Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa Visceral Pain Revenue and Revenue Share by Application (2013-2018)
10 Global Visceral Pain Market Segment by Type
10.1 Global Visceral Pain Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Visceral Pain Sales and Market Share by Type (2013-2018)
10.1.2 Global Visceral Pain Revenue and Market Share by Type (2013-2018)
10.2 Analgesics Sales Growth and Price
10.2.1 Global Analgesics Sales Growth (2013-2018)
10.2.2 Global Analgesics Price (2013-2018)
10.3 Pain Modifiers Sales Growth and Price
10.3.1 Global Pain Modifiers Sales Growth (2013-2018)
10.3.2 Global Pain Modifiers Price (2013-2018)
11 Global Visceral Pain Market Segment by Application
11.1 Global Visceral Pain Sales Market Share by Application (2013-2018)
11.2 Interstitial Cystitis Sales Growth (2013-2018)
11.3 Crohn’s Sales Growth (2013-2018)
11.4 Irritable Bowel Sales Growth (2013-2018)
11.5 Chronic Prostatitis Sales Growth (2013-2018)
12 Visceral Pain Market Forecast (2018-2023)
12.1 Global Visceral Pain Sales, Revenue and Growth Rate (2018-2023)
12.2 Visceral Pain Market Forecast by Regions (2018-2023)
12.2.1 North America Visceral Pain Market Forecast (2018-2023)
12.2.2 Europe Visceral Pain Market Forecast (2018-2023)
12.2.3 Asia-Pacific Visceral Pain Market Forecast (2018-2023)
12.2.4 South America Visceral Pain Market Forecast (2018-2023)
12.2.5 Middle East and Africa Visceral Pain Market Forecast (2018-2023)
12.3 Visceral Pain Market Forecast by Type (2018-2023)
12.3.1 Global Visceral Pain Sales Forecast by Type (2018-2023)
12.3.2 Global Visceral Pain Market Share Forecast by Type (2018-2023)
12.4 Visceral Pain Market Forecast by Application (2018-2023)
12.4.1 Global Visceral Pain Sales Forecast by Application (2018-2023)
12.4.2 Global Visceral Pain Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Visceral Pain Picture
Table Product Specifications of Visceral Pain
Figure Global Visceral Pain CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
